Zalicus
SITE MAP   |   CAREERS   |   CONTACT   |   
Discovery Technologies
Zalicus - Your Partner for Combination Drug Discovery
 

Zalicus has two unique drug discovery platforms that fuel its product pipeline and enable additional revenue generating collaborations. Our industry leading selective ion channel modulation expertise, in collaboration with Hydra Biosciences, allows us to identify product candidates that harness the potential of the electrophysiology of calcium and sodium channel blockers for acute and chronic pain. Our proprietary cell-based combination High Throughput Screening (cHTS) technology evaluates the therapeutic potential of various drug combinations while elucidating new mechanisms to treat diseases.